Optimization of Receptor Occupancy Assays in Mass Cytometry: Standardization Across Channels with QSC Beads

Heparin reduces nonspecific eosinophil staining artifacts in mass cytometry experiments

(2016) Adeeb H. Rahman et al.   CYTOMETRY PART A

Mass cytometry panel optimization through the designed distribution of signal interference

(2016) Chikara Takahashi et al.   CYTOMETRY PART A

Role of receptor occupancy assays by flow cytometry in drug development

(2016) Jennifer J. Stewart et al.   CYTOMETRY PART B-CLINICAL CYTOMETRY

Evaluating the efficiency of isotope transmission for improved panel design and a comparison of the detection sensitivities of mass cytometer instruments

(2015) Sabine Tricot et al.   CYTOMETRY PART A

Implementing Mass Cytometry at the Bedside to Study the Immunological Basis of Human Diseases: Distinctive Immune Features in Patients with a History of Term or Preterm Birth

(2015) Brice Gaudillière et al.   CYTOMETRY PART A

How validated receptor occupancy flow cytometry assays can impact decisions and support drug development

(2015) Maxime Moulard et al.   CYTOMETRY PART B-CLINICAL CYTOMETRY

Single-cell systems-level analysis of human Toll-like receptor activation defines a chemokine signature in patients with systemic lupus erythematosus

(2015) William E. O'Gorman et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Mass cytometry as a platform for the discovery of cellular biomarkers to guide effective rheumatic disease therapy

(2015) Nitya Nair et al.   ARTHRITIS RESEARCH & THERAPY

VLA-4 blockade promotes differential routes into human CNS involving PSGL-1 rolling of T cells and MCAM-adhesion of TH17 cells

(2014) Tilman Schneider-Hohendorf et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Clinical recovery from surgery correlates with single-cell immune signatures

(2014) B. Gaudilliere et al.   Science Translational Medicine

Natalizumab saturation: biomarker for individual treatment holiday after natalizumab withdrawal?

(2013) P. Wipfler et al.   ACTA NEUROLOGICA SCANDINAVICA

Randomized, Double-Blind, Placebo-Controlled, Dose-Escalating Phase I, Healthy Subjects Study of Intravenous OPN-305, a Humanized Anti-TLR2 Antibody

(2013) M Reilly et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

A phase 1 study of lucatumumab, a fully human anti-CD40 antagonist monoclonal antibody administered intravenously to patients with relapsed or refractory multiple myeloma

(2012) William Bensinger et al.   BRITISH JOURNAL OF HAEMATOLOGY

A quantitative flow cytometric assay for determining binding characteristics of chimeric, humanized and human antibodies in whole blood: Proof of principle with rituximab and ofatumumab

(2012) Patrick J. Engelberts et al.   JOURNAL OF IMMUNOLOGICAL METHODS

Quality assurance for polychromatic flow cytometry using a suite of calibration beads

(2012) Stephen P Perfetto et al.   Nature Protocols

Mass Cytometry: Technique for Real Time Single Cell Multitarget Immunoassay Based on Inductively Coupled Plasma Time-of-Flight Mass Spectrometry

(2009) Dmitry R. Bandura et al.   ANALYTICAL CHEMISTRY